Literature DB >> 11571947

Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.

H Yamada1, S Kondo, S Okushiba, T Morikawa, H Katoh.   

Abstract

Hepatectomy for liver metastases from colorectal cancer has recently received general acceptance as a safe, potentially curative treatment. Most patients, however, die of recurrent disease after hepatectomy. The predictive factors for recurrence after first resection of liver metastases have not yet been clarified. The authors aimed to determine the factors that can predict recurrence, especially hepatic-only recurrence after hepatectomy for colorectal liver metastases. Seventy-six patients who underwent liver resection of colorectal metastases were studied retrospectively. Forty-seven (61.8%) of the patients had a recurrence. The patients' disease-free survival after first hepatectomy and the second recurrence sites were univariately and multivariately analyzed using 16 clinicopathologic variables. Wall invasion, lymph node metastases, lymphatic invasion, venous invasion of the primary tumor, 24 months or longer disease-free interval after resection of the primary colorectal cancer, and bilateral liver metastases significantly influenced the disease-free survival (log-rank test: p < 0.05). The multivariate analysis revealed that venous invasion of the primary tumor and bilateral hepatic metastases were independent risk factors for recurrence after hepatectomy. The liver was the only site of second recurrence in 23 patients. Patients with lymph node metastases and venous invasion of the primary tumor had a significant difference between hepatic-only and extrahepatic recurrence after first hepatectomy (chi-square test or Fishers' exact test: p < 0.05). Recurrence after hepatectomy was influenced more by factors associated with the primary colorectal cancer than factors surrounding the first liver metastases. Venous invasion of the primary colorectal cancer was the most important predictable factor for hepatic-only second recurrence.

Entities:  

Mesh:

Year:  2001        PMID: 11571947     DOI: 10.1007/bf03215859

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Late results justify resection for multiple hepatic metastases from colorectal cancer.

Authors:  M Rees; G Plant; S Bygrave
Journal:  Br J Surg       Date:  1997-08       Impact factor: 6.939

2.  Repeat hepatic resection for recurrent colorectal cancer.

Authors:  Q D Chu; M P Vezeridis; K A Avradopoulos; H J Wanebo
Journal:  World J Surg       Date:  1997 Mar-Apr       Impact factor: 3.352

3.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  Surgical experience with hepatic colorectal metastasis.

Authors:  A L Bradley; W C Chapman; J K Wright; J W Marsh; S Geevarghese; K T Blair; C W Pinson
Journal:  Am Surg       Date:  1999-06       Impact factor: 0.688

5.  Hepatic resection for colorectal metastases: analysis of prognostic factors.

Authors:  S Ambiru; M Miyazaki; T Isono; H Ito; K Nakagawa; H Shimizu; K Kusashio; S Furuya; N Nakajima
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

6.  Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie.

Authors:  D Jaeck; P Bachellier; M Guiguet; K Boudjema; J C Vaillant; P Balladur; B Nordlinger
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

7.  Repeat hepatectomy for colorectal liver metastases.

Authors:  R Adam; H Bismuth; D Castaing; F Waechter; F Navarro; A Abascal; P Majno; L Engerran
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

8.  Survival after repeat hepatic resection for recurrent colorectal metastases.

Authors:  A Chiappa; A P Zbar; F Biella; C Staudacher
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

9.  Determinants of survival following hepatic resection for metastatic colorectal cancer.

Authors:  E A Bakalakos; J A Kim; D C Young; E W Martin
Journal:  World J Surg       Date:  1998-04       Impact factor: 3.352

10.  Hepatic resection for metastases from colorectal carcinoma--a survival analysis.

Authors:  G R Jatzko; P H Lisborg; H M Stettner; M H Klimpfinger
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

View more
  14 in total

1.  Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.

Authors:  Moritz Koch; Peter Kienle; Ulf Hinz; Dalibor Antolovic; Jan Schmidt; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

2.  Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases.

Authors:  N W Molla; M M Hassanain; Z Fadel; L M Boucher; A Madkhali; R M Altahan; E A Alrijraji; E B Simoneau; H Alamri; A Salman; Z Gao; P P Metrakos
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

3.  Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Yoshirou Fujii; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  Langenbecks Arch Surg       Date:  2004-07-03       Impact factor: 3.445

4.  Surgical treatment of liver metastases from colorectal cancer in elderly patients.

Authors:  Gianluca Mazzoni; Adriano Tocchi; Michelangelo Miccini; Elia Bettelli; Diletta Cassini; Monica De Santis; Lidia Colace; Stefania Brozzetti
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

5.  Hepatic resection in stage IV colorectal cancer: prognostic predictors of outcome.

Authors:  Adriano Tocchi; Gianluca Mazzoni; Stefania Brozzetti; Michelangelo Miccini; Diletta Cassini; Elia Bettelli
Journal:  Int J Colorectal Dis       Date:  2004-04-22       Impact factor: 2.571

6.  Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.

Authors:  Robert P Jones; Declan Dunne; Paul Sutton; Hassan Z Malik; Stephen W Fenwick; Monica Terlizzo; Elizabeth O'Grady; Claus Koelblinger; Stefan Stättner; Stefan Stremitzer; Thomas Gruenberger; Graeme J Poston
Journal:  HPB (Oxford)       Date:  2012-10-16       Impact factor: 3.647

7.  Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer.

Authors:  Marcella Arru; Luca Aldrighetti; Renato Castoldi; Saverio Di Palo; Elena Orsenigo; Marco Stella; Carlo Pulitanò; Francesca Gavazzi; Gianfranco Ferla; Valerio Di Carlo; Carlo Staudacher
Journal:  World J Surg       Date:  2008-01       Impact factor: 3.352

8.  Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation.

Authors:  A R Gillams; W R Lees
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

9.  Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Masaru Miura; Yoshiro Fujii; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

10.  Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer.

Authors:  Bo Yu; Shi-Yong Li; Ping An; Ying-Nan Zhang; Zhen-Jia Liang; Shu-Jun Yuan; Hui-Yun Cai
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.